Bibliography
- Chesbrough HW . Open Innovation: The New Imperative For Creating and Profiting From Technology. Harvard Business School Press Books, Boston, MA, USA, 24 (2003).
- Hunter J , StephensS. Is open innovation the way forward for big pharma?Nat. Rev. Drug Discov.9, 87–88 (2010).
- Hu M , SchultzK, SheuJ, TschoppD. Kellogg school of management report: the innovation gap in pharmaceutical drug discovery & new models for R&D success. (2007).
- Talaga P . Open innovation share or die.Drug Discov. Today14, 21–22(2009).
- Hotez P , MolyneuxH, FenwickAet al. Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018–1027 (2007).
- Kilama WL . The 10.90 gap in sub-Saharan Africa: resolving inequities in health research. Acta Trop.112. S8–S15 (2009).
- Gustavsen K , HansonC. Progress in public–private partnerships to fight neglected diseases.Health Aff.28, 1745–1749 (2009).
- Munos B . Can open-source R&D reinvigorate drug research?Nat. Rev. Drug Discov.5, 723–729 (2006).
- Mullin R . Paying attention to neglected diseases: the drugs for neglected diseases initiative is mobilizing public/private partnerships.Chem. Eng. News87(16), 21–24 (2009).
- Grose S . Online resource aims to smooth the biomed patent search.Nat. Med.15, 1242 (2009).
- Nwaka S , RamirezB, BrunR, MaesL, DouglasF, RidleyR. Advancing drug innovation for neglected diseases – criteria for lead progression.PLoS Negl. Trop. Dis.3(8), e440 (2009).
- Callan B , IainG. The path to new medicines.Nature449, 164–165 (2007).
- Senderovitz T . How open innovation could reinvigorate the pharmaceutical industry with fresh R&D opportunities.Expert Rev. Clin. Pharmacol.2(6), 585–587 (2009).
Websites
- The in vivo blog. Sticker shock may open innovation in pharma (2009) http://invivoblog.blogspot.com/2009/03/sticker-shock-may-open-innovation-in.html
- Centers for disease control and prevention. Impact of malaria (2010) www.cdc.gov/malaria/malaria_worldwide/impact.htm
- Centers for disease control and prevention. Tuberculosis: data and statistics (2010) www.cdc.gov/tb/statistics/default.htm
- Eliminating river blindness: Merck and Co. Inc. and Ivermectin, against Onchocerca volvulus (2007) http://human-infections.suite101.com/article.cfm/eliminating_river_blindness
- GlaxoSmithKline announces open innovation plans (2010) http://opensource.com/business/10/1/glaxosmithkline-announces-open-innovation-plans
- Massachusetts Institute of Technology (MIT) joins pool for open innovation against neglected tropical diseases (2010) www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100505006034&newsLang=en
- Novartis to partner with OneWorld Health to develop diarrhea drug (2009) http://www.medicalnewstoday.com/articles/157581.php
- Big pharma and neglected diseases (2008) http://spicyipindia.blogspot.com/2008/03/big-pharma-and-neglected-diseases.html
- Indian scientists refuse to patent tuberculosis genome, encourage anyone to make the drugs (2010) www.techdirt.com/blog/itinnovation/articles/20100412/0118378969.shtml